These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11724104)

  • 1. FDA labeling system for drugs in pregnancy.
    Boothby LA; Doering PL
    Ann Pharmacother; 2001 Nov; 35(11):1485-9. PubMed ID: 11724104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Content and format of labeling for human prescription drugs; pregnancy labeling; public hearing--FDA. Notice of public hearing; request for comments.
    Fed Regist; 1997 Jul; 62(147):41061-3. PubMed ID: 10169832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA's proposed rule for pregnancy and lactation labeling: improving maternal child health through well-informed medicine use.
    Feibus KB
    J Med Toxicol; 2008 Dec; 4(4):284-8. PubMed ID: 19031382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent changes in pregnancy and lactation labeling: retirement of risk categories.
    Ramoz LL; Patel-Shori NM
    Pharmacotherapy; 2014; 34(4):389-95. PubMed ID: 24390829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA drug labeling for pregnancy and lactation drug safety monitoring systems.
    Greene MF
    Semin Perinatol; 2015 Nov; 39(7):520-3. PubMed ID: 26428020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Categorizing the safety of medications during pregnancy and lactation.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2009 Apr; 47(4):17-20. PubMed ID: 19437927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes to Pregnancy and Lactation Risk Labeling for Prescription Drugs.
    Fantasia HC; Harris AL
    Nurs Womens Health; 2015; 19(3):266-70. PubMed ID: 26058910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The US FDA pregnancy lactation and labeling rule - Implications for maternal immunization.
    Gruber MF
    Vaccine; 2015 Nov; 33(47):6499-500. PubMed ID: 26256527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the new pregnancy and lactation drug labeling.
    Watkins EJ; Archambault M
    JAAPA; 2016 Feb; 29(2):50-2. PubMed ID: 26818647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 2015 US Food and Drug Administration Pregnancy and Lactation Labeling Rule.
    Brucker MC; King TL
    J Midwifery Womens Health; 2017 May; 62(3):308-316. PubMed ID: 28556499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Drug Labels Following the 2015 Pregnancy and Lactation Labeling Rule.
    Byrne JJ; Saucedo AM; Spong CY
    JAMA Netw Open; 2020 Aug; 3(8):e2015094. PubMed ID: 32865574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychiatric Medications and Reproductive Safety: Scientific and Clinical Perspectives Pertaining to the US FDA Pregnancy and Lactation Labeling Rule.
    Freeman MP; Farchione T; Yao L; Sahin L; Taylor L; Huybrechts KF; Nonacs R; Sosinsky AZ; Viguera AC; Cohen LS
    J Clin Psychiatry; 2018 Jul; 79(4):. PubMed ID: 30153401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the Pregnancy and Lactation Labeling Rule (PLLR) on Practicing Dermatologists.
    Beroukhim K; Abrouk M; Farahnik B
    Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Influence of the Food and Drug Administration Pregnancy and Lactation Labeling Rule on Drug Information Resources.
    Harris JB; Holmes AP; Eiland LS
    Ann Pharmacother; 2021 Apr; 55(4):459-465. PubMed ID: 32885981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of drugs for unlabeled indications.
    Erickson SH; Bergman JJ; Schneeweiss R; Cherkin DC
    JAMA; 1980 Apr; 243(15):1543-6. PubMed ID: 7359738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing congenital malformation risk from medications used in pregnancy: The contribution of NBDPS in pregnancy labeling of prescription drug products.
    Tassinari MS; Sahin L; Yao LP
    Birth Defects Res A Clin Mol Teratol; 2015 Aug; 103(8):718-20. PubMed ID: 26223007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2014 Dec; 79(233):72063-103. PubMed ID: 25509060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is prescription labeling communicating to doctors about hepatotoxic drugs? A study of FDA approved product labeling.
    Willy ME; Li Z
    Pharmacoepidemiol Drug Saf; 2004 Apr; 13(4):201-6. PubMed ID: 15255086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sources of drug information: FDA-approved labeling and other official FDA sources.
    Lindstrom JA
    Dermatol Ther; 2009; 22(3):246-56. PubMed ID: 19453349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.